IDDM stands for insulin-dependent diabetes mellitus, an older medical term for what is now called type 1 diabetes. It replaced an even earlier name, “juvenile-onset diabetes,” and was itself phased out as doctors moved toward a simpler numbering system. If you see IDDM in a textbook, lab report, or older medical record, it refers to the same autoimmune condition that affects roughly 9 million people worldwide, including about 1.8 million children under 20.
Why the Name Changed
For decades, doctors classified diabetes by how it was treated: insulin-dependent (IDDM) or noninsulin-dependent (NIDDM). The problem was that many people with type 2 diabetes eventually need insulin too, making the label misleading. The American Diabetes Association shifted to “type 1” and “type 2” to describe the underlying cause of each condition rather than its treatment. You’ll still encounter IDDM in older research papers, insurance codes, and some international guidelines, but it means exactly the same thing as type 1 diabetes.
What Happens in the Body
Type 1 diabetes is an autoimmune disease. The immune system mistakenly identifies the insulin-producing cells in the pancreas (called beta cells) as threats and destroys them. Immune cells infiltrate the clusters of beta cells, release inflammatory signals, and attract more immune cells to the area. Specialized killer cells then lock onto the beta cells and trigger their death.
The result is an absolute insulin deficiency. Without insulin, your body cannot move sugar from the bloodstream into cells for energy. Blood sugar rises unchecked, and the body starts breaking down fat and muscle for fuel, which is why unexplained weight loss is one of the earliest signs.
Common Symptoms at Onset
The classic signs tend to develop over days to weeks, not gradually over years like type 2 diabetes. In studies of newly diagnosed patients, the most frequently reported symptoms are:
- Frequent urination (polyuria), reported in about 60% of cases
- Excessive thirst (polydipsia), around 56%
- Persistent fatigue, about 50%
- Unexplained weight loss, roughly 38%
- Increased hunger, especially despite eating normally
If blood sugar climbs high enough before diagnosis, a dangerous condition called diabetic ketoacidosis can develop. This happens when the body produces high levels of acids (ketones) from burning fat. Symptoms include nausea, vomiting, abdominal pain, fruity-smelling breath, and confusion. It requires emergency treatment.
How It Is Diagnosed
Diabetes is confirmed when blood sugar exceeds specific thresholds on standardized tests. Any one of the following meets the diagnostic criteria set by the American Diabetes Association:
- A1C of 6.5% or higher, which reflects average blood sugar over the past two to three months
- Fasting blood sugar of 126 mg/dL or higher after at least eight hours without food
- Two-hour blood sugar of 200 mg/dL or higher during an oral glucose tolerance test
- Random blood sugar of 200 mg/dL or higher along with classic symptoms like excessive thirst and frequent urination
Once diabetes is confirmed, distinguishing type 1 from type 2 often involves a C-peptide test. C-peptide is a byproduct of insulin production, so very low levels (below 0.24 ng/mL) indicate the pancreas is making little to no insulin on its own. Autoantibody blood tests can also confirm that the immune system is actively targeting beta cells.
The Honeymoon Phase
Shortly after diagnosis and the start of insulin therapy, many people experience a temporary period of near-normal blood sugar with reduced insulin needs. This “honeymoon phase” typically begins around three months after starting treatment and can last anywhere from a few months to about a year. During this window, some surviving beta cells recover function, partly because externally supplied insulin gives them a break from overproduction. The honeymoon phase always ends as the immune system continues its attack, and insulin requirements gradually increase to their long-term levels.
Daily Management With Insulin
Because the pancreas produces little to no insulin, people with type 1 diabetes replace it externally for the rest of their lives. The standard approach uses two types of insulin working together: a long-acting insulin that provides a steady baseline throughout the day, and a rapid-acting insulin taken before meals to handle the sugar from food.
The premeal dose is calculated based on how many carbohydrates are in the meal (using a personalized ratio) plus a correction if blood sugar is already running high. This can be done through multiple daily injections with a pen or syringe, or through an insulin pump that delivers small amounts continuously through a tiny tube under the skin.
Continuous glucose monitors have become a major tool for daily management. These small sensors, worn on the skin, measure blood sugar every few minutes and display trends on a phone or receiver. Current guidelines recommend wearing a monitor at least 14 days at a time and aiming to keep blood sugar between 70 and 180 mg/dL for at least 70% of the day. Keeping blood sugar variability low, with a coefficient of variation at or below 36%, is equally important for reducing complications.
Handling Low Blood Sugar
Insulin therapy carries the risk of blood sugar dropping too low (hypoglycemia), which can cause shakiness, sweating, confusion, irritability, and in severe cases, loss of consciousness. The standard response is the 15-15 rule: consume 15 to 20 grams of fast-acting carbohydrates, such as glucose tablets, juice, or regular soda, then recheck your blood sugar after 15 minutes. If it’s still below 70 mg/dL, repeat until it rises above that threshold.
Severe episodes where a person can’t eat or drink on their own require glucagon, a hormone that rapidly raises blood sugar. Glucagon kits (available as injections or nasal sprays) should be kept accessible, and family members or close contacts should know how to use them. If glucagon isn’t available and someone is unconscious, call emergency services immediately and do not attempt to put food or drink in their mouth.
Long-Term Complications
Years of elevated blood sugar damages blood vessels throughout the body. The landmark Diabetes Control and Complications Trial demonstrated that keeping A1C near 7% (compared to 9%) reduced the development and progression of major complications by 50 to 76%. The damage falls into two broad categories.
Small blood vessel damage (microvascular) drives three of the most common complications. Retinopathy affects the blood vessels in the eyes and can lead to vision loss. Nephropathy, or kidney disease, develops in 20 to 40% of adults with diabetes over time. Neuropathy damages nerves, most often in the feet and hands, causing numbness, tingling, or pain. Poor circulation and nerve damage together also slow wound healing, especially in the lower legs and feet, where minor cuts can develop into serious infections.
Large blood vessel damage (macrovascular) accelerates the buildup of plaque in arteries, raising the risk of heart attacks, strokes, and poor circulation in the legs. Erectile dysfunction is also common and can result from a combination of nerve damage and blood vessel problems.
Who Gets Type 1 Diabetes
Type 1 diabetes can develop at any age, though it most commonly appears in childhood and adolescence. Globally, an estimated 9.2 million people were living with the condition in 2024. Researchers have also identified that an additional 3.7 million people may have died prematurely due to the disease, particularly in regions with limited access to insulin. Screening studies in children suggest that about 0.3% of the general pediatric population may be in earlier, presymptomatic stages where autoimmunity has begun but blood sugar hasn’t risen enough to cause symptoms yet. These stages are increasingly being identified through research screening programs, opening the door to earlier monitoring and intervention.